2023 annual financial data
Xenetic Biosciences 2023 Net margin
Direct answer
Net margin was -162.78%.
Operating income was -4.52M USD and net income was -4.13M USD.
Operating cash flow was -4.11M USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2.54M USD
- Operating income
- -4.52M USD
- Net income
- -4.13M USD
- Operating cash flow
- -4.11M USD